on CARMAT (EPA:ALCAR)
CARMAT makes its first sales of artificial hearts in Israel
CARMAT announces that it has carried out the first commercial implantations of its Aeson® artificial heart outside the European Union. Two devices were recently implanted in Israel.
The first procedure took place at Hadassah Hospital Ein Kerem in Jerusalem, led by Prof. Offer Amir among other specialists. The second implantation took place at Sheba Medical Center in Tel Aviv, led by Dr. Jeff Morgan and his team.
CARMAT is thus expanding its international presence, bringing to five the number of countries where commercial establishments have been established, thus illustrating the growing interest in this therapeutic alternative.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all CARMAT news